Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.45) by 33.33 percent. This is a 54.55 percent increase over losses of $(0.67) per share from the same period last year. The company reported quarterly sales of $247.221 million which beat the analyst consensus estimate of $241.125 million by 2.53 percent. This is a 5.46 percent increase over sales of $234.422 million the same period last year.